THE ASSAY AND PROPERTIES OF LABILE FACTOR (FACTOR V)

AUTOR(ES)

Quick, Armand J.

RESUMO

Human oxalated plasma stored at 4° C. until the prothrombin time is increased beyond 60 sec. is a reliable medium for assaying labile factor (factor V) because its response to added labile factor corresponds quantitatively to that of plasma from patients with congenital deficiency of this factor. Such an agreement is not obtained with plasma stored at 37°C. The stability of labile factor is closely associated with ionized calcium. The addition of thrombin to fresh oxalated plasma causes an apparent hyperactivity of labile factor, but this is completely removed by adsorption with Ca3(PO)2. Oxalated plasma when adsorbed with Ca3(PO4)2 before treatment with thrombin does not develop this adventitious activity, nor does it occur in stored plasma treated with thrombin. The seemingly high labile factor activity in serum can be explained by the activation of this factor which is independent of labile factor but acts synergistically with it. The true labile factor concentration can be determined only after the accelerator is removed by adsorption with Ca3(PO4)2. A close agreement between the consumption of prothrombin and the loss of labile factor during clotting is observed.

Documentos Relacionados

• Immunologic differentiation of classic hemophilia (factor VIII deficiency) and von Willebrand's disease: With observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor
• Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor VIII)
• The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
• Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.
• Study of the Adsorption of Arsenic (III and V) by Magnetite Nanoparticles Synthetized via AACVD